Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Wednesday, October 20, 2021 8:21:19 AM
We don't know the exact yet the number of Compassionate Use cases either ... in FL locale (or elsewhere) who have received FULL DOSAGE of Brilacidin...but it is a reasonable guess that there are likely more than have been rumored on social media...and we don't know how much greater the dosages of Brilacidin are being administered... based upon patients being in dire and critical condition (perhaps we will hear of evidence of greater efficacy with greater dosing!).
What we do know is via BREAK-THOUGH (Colin Powell) cases becoming more and more prevalent that VACCINES ARE NOT THE SOLUTION...
What good are vaccines for those in the "vulnerable" class whose bodies might not be able to produce sufficient antibodies after receiving the vaccine to combat the Covid?
DR. Gottlieb was interviewed on CNBC this AM and said "VACCINES will not be sufficient for the vulnerable population, their Immune systems are compromised and may not make the necessary anti-bodies to protect them"..."We need Therapeutics to act as a prophylactics"
Who are the "most vulnerable"?... According to Gottlieb, look no further than ANYONE WITH A COMPROMISED IMMUNE SYSTEM...due to AGE or PRE-EXISTING MEDICAL CONDITIONS...
...meaning... a huge swatch of the population are going to be in need of an EFFECTIVE PROPHYLACTIC THERAPEUTIC...which Brilacidin was identified potentially EFFECTIVE as one...by GMU/RBL
IMO ... Gottlieb's statement is the canary in the coal mine...It appears CDC/FDA (and BP) are finally realizing Covid destruction is not going to be curtailed with Vaccines and in the absence of EFFECTIVE AND BROAD THERAPEUTIC WHICH KILLS ON CONTACT (Prophylactic) That interview appears to be an indicator that the Med Community is finally going to head first into Therapeutics...
IMO Brilacidin's top-line demonstrating efficacy above Remdesivir will be lighting the rocket fuse... for Brilacidin...
Know what you own...IMO less than 10 days away from TOP-LINE
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM